16.05.2023

VERY STRONG SALES AND EARNINGS INCREASE IN THE FIRST QUARTER 2023

Donaueschingen, 16/05/2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 11% and EBIT by approx. 28% in the first three months of 2023. As a result, the continually positive development of sales and earnings of the last years could be continued.

Sales improved from KEUR 49,498 to KEUR 55,020 (+11.2%) in the first three months 2023. The international share of total business volume was 47.6% ((3M-2022) 48.1%) and amounted to KEUR 26,205 compared to KEUR 23,785 (3M-2022).

The consolidated earnings before interest and taxes (EBIT) rose very sharply by 28.5% to KEUR 7,688 ((3M-2022) KEUR 5,985). The consolidated earnings before taxes (EBT) developed very positively. It improved by 42.4% to KEUR 8,074 (3M 2022: 5,669).

The EBITDA increased by 14.0% to KEUR 11,602 ((3M-2022) KEUR 10,175). The EBITA increased by 21.8% from KEUR 7,161 (3M-2022) to KEUR 8,721 an the consolidated surplus rose by 28.7% to KEUR 5,654 ((3M-2022) KEUR 4,393).

As of 31/03/2023, the company had cash resources at its disposal in the amount of KEUR 129,158 (31/12/2022: KEUR 110,019). Nexus AG had equity capital amounting to KEUR 243,434 as of 31/03/2023 (31/12/2022: KEUR 238,946). Consequently, the equity capital rate is 65.3% (31/12/2022: 69.4%).

Downloads

You might also be interested in

- NEXUS-Gruppe
VERY STRONG REVENUES AND EARNINGS INCREASE IN 2022

Donaueschingen, 07/03/2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its revenues by 11.1% and EBIT by 15.2% in the fiscal year 2022. As a result, the continually positive development of revenues and earnings of the last two decades could be continued.
- NEXUS-Gruppe
Strong sales and earnings increase in the first half-year 2023

Donaueschingen, 15 August 2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by approx. 12% and EBT by 23% in the first six months of 2023. As a result, the continually positive development of sales and earnings of the last years could be continued.
- NEXUS-Gruppe
Very strong sales and earnings increase in the third quarter 2023

Donaueschingen, 07/11/2023: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 14% and EBT by approx. 33% in the first nine months of 2023. As a result, the continually positive development of sales and earnings of the last years could be continued.
- NEXUS-Gruppe
VERY STRONG REVENUES AND EARNINGS INCREASE IN 2023

Donaueschingen, 05/03/2024: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its revenues by 15.5% and EBT by 21% in the fiscal year 2023. As a result, the continually positive development of revenues and earnings of the last two decades could be continued.
- NEXUS-Gruppe
VERY STRONG SALES AND EARNINGS INCREASE IN THE FIRST QUARTER 2024

Donaueschingen, 14/05/2024: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 15% and EBITDA by approx. 12% in the first three months of 2024. As a result, the continually positive development of sales and earnings of the last years could be continued.